Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, ...
Researchers discover that the COVID-19 virus can trigger the production of 'abzymes' -- antibodies that act like enzymes -- which may explain why long COVID symptoms persist even after the infection ...
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
HealthinationA Quick Guide for the Coronavirus Outbreak.On March 11, WHO officially declared COVID-19 a pandemic. With much of the country taking steps to open up now or in the near future, hopes are ...
CHICAGO (NewsNation Now) — The U.S. Food and Drug Administration (FDA) issued an emergency use approval for Abbott’s latest lab-based COVID-19 IgM antibody test, the company announced Monday. Abbott ...
Individuals with comorbidities, particularly type 2 diabetes (T2D), were considered the most vulnerable subgroups during the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute ...
As access to COVID-19 vaccines dwindles in the US, one company seems to be positioning its products as an alternative way of preventing the disease. Invivyd is the manufacturer of pemivibart, a ...
Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results